Overview
This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.
Eligibility
Inclusion Criteria:
- patients scheduled for modified radical mastectomy,
- Age 18-65 years,
- ASA I-II
Exclusion Criteria:
- patient refusal,
- coagulation defects,
- abnormal kidney or liver functions,
- local infection at site of injection.